Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Systems and methods for assessing heart failure and controlling cardiac resynchronization therapy using hybrid impedance measurement configurations

US Patent 8750981 · Granted Jun 10, 2014

Estimated economic value: $11,703,000

Assignee

Inventors

View full patent text on Google Patents →